Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancerDong Hoon Shin, Sang Soo Kim|Experimental & Molecular Medicine|2023Cited by 18
Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumorsEun Kyung Choi, Sang Soo Kim|Experimental & Molecular Medicine|2018Cited by 15
Inhibition of Estrogen Signaling Reduces the Incidence of <i>BRCA1</i>-associated Mammary Tumor FormationHye Jung Baek, Sang Soo Kim|International Journal of Biological Sciences|2018Cited by 12
Oncogenic KRAS mutation confers chemoresistance by upregulating SIRT1 in non-small cell lung cancerDong Hoon Shin, Sang Soo Kim|Research Square|2023Cited by 1